FENUZIP Trademark

Trademark Overview

On Monday, January 14, 2013, a trademark application was filed for FENUZIP with the United States Patent and Trademark Office. The USPTO has given the FENUZIP trademark a serial number of 85822114. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2017. This trademark is owned by Novartis AG. The FENUZIP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals
fenuzip

General Information

Serial Number85822114
Word MarkFENUZIP
Filing DateMonday, January 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, April 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 17, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2016EXTENSION 5 GRANTED
Wednesday, September 7, 2016EXTENSION 5 FILED
Wednesday, September 7, 2016TEAS EXTENSION RECEIVED
Wednesday, March 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 22, 2016EXTENSION 4 GRANTED
Tuesday, March 8, 2016EXTENSION 4 FILED
Tuesday, March 8, 2016TEAS EXTENSION RECEIVED
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 27, 2015EXTENSION 3 GRANTED
Thursday, September 10, 2015EXTENSION 3 FILED
Thursday, September 10, 2015TEAS EXTENSION RECEIVED
Thursday, April 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2015EXTENSION 2 GRANTED
Monday, March 9, 2015EXTENSION 2 FILED
Thursday, April 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 9, 2015TEAS EXTENSION RECEIVED
Friday, September 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 10, 2014EXTENSION 1 GRANTED
Wednesday, September 10, 2014EXTENSION 1 FILED
Wednesday, September 10, 2014TEAS EXTENSION RECEIVED
Tuesday, March 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 12, 2013ASSIGNED TO LIE
Monday, November 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 5, 2013EXAMINER'S AMENDMENT ENTERED
Monday, November 4, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2013EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 26, 2013NON-FINAL ACTION E-MAILED
Friday, April 26, 2013NON-FINAL ACTION WRITTEN
Friday, April 26, 2013ASSIGNED TO EXAMINER
Friday, January 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

fenuzip pharmaceutical preparations system disorders treatment prevention diseases namely anti ocular